These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10395282)

  • 41. Molecular modeling of a phenyl-amidine class of NMDA receptor antagonists and the rational design of new triazolyl-amidine derivatives.
    Abreu PA; Castro HC; Paes-de-Carvalho R; Rodrigues CR; Giongo V; Paixão IC; Santana MV; Ferreira JM; Caversan OM; Leão RA; Marins LM; Henriques AM; Farias FM; Albuquerque MG; Pinheiro S
    Chem Biol Drug Des; 2013 Feb; 81(2):185-97. PubMed ID: 22985449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Xenon as neuroprotectant in acute stroke?
    Altschuler EL
    Med Hypotheses; 2001 Feb; 56(2):227-8. PubMed ID: 11425293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-activity relationships for a series of bis(phenylalkyl)amines: potent subtype-selective inhibitors of N-methyl-D-aspartate receptors.
    Tamiz AP; Whittemore ER; Zhou ZL; Huang JC; Drewe JA; Chen JC; Cai SX; Weber E; Woodward RM; Keana JF
    J Med Chem; 1998 Aug; 41(18):3499-506. PubMed ID: 9719603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The N-methyl-D-aspartate receptor inhibitory potencies of aromatic inhaled drugs of abuse: evidence for modulation by cation-pi interactions.
    Raines DE; Gioia F; Claycomb RJ; Stevens RJ
    J Pharmacol Exp Ther; 2004 Oct; 311(1):14-21. PubMed ID: 15166258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure-activity relationships of 1,4-dihydro-(1H,4H)-quinoxaline-2,3-diones as N-methyl-D-aspartate (glycine site) receptor antagonists. 1. Heterocyclic substituted 5-alkyl derivatives.
    Fray MJ; Bull DJ; Carr CL; Gautier EC; Mowbray CE; Stobie A
    J Med Chem; 2001 Jun; 44(12):1951-62. PubMed ID: 11384240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ARR 15896 AR. ARL 15896, ARL 15896AR, ARR 15896, FPL 15896, FPL 15896AR.
    Drugs R D; 1999 Jan; 1(1):14-5. PubMed ID: 10565970
    [No Abstract]   [Full Text] [Related]  

  • 47. Enantiomerically Pure 2-Methyltetrahydro-3-benzazepin-1-ols Selectively Blocking GluN2B Subunit Containing N-Methyl-D-aspartate Receptors.
    Tewes B; Frehland B; Schepmann D; Robaa D; Uengwetwanit T; Gaube F; Winckler T; Sippl W; Wünsch B
    J Med Chem; 2015 Aug; 58(15):6293-305. PubMed ID: 26186074
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity studies of conantokins as human N-methyl-D-aspartate receptor modulators.
    Nielsen KJ; Skjaerbaek N; Dooley M; Adams DA; Mortensen M; Dodd PR; Craik DJ; Alewood PF; Lewis RJ
    J Med Chem; 1999 Feb; 42(3):415-26. PubMed ID: 9986713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural modifications to an N-methyl-D-aspartate receptor antagonist result in large differences in trapping block.
    Mealing GA; Lanthorn TH; Small DL; Murray RJ; Mattes KC; Comas TM; Morley P
    J Pharmacol Exp Ther; 2001 Jun; 297(3):906-14. PubMed ID: 11356910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death.
    Seo SY; Yun BS; Ryoo IJ; Choi JS; Joo CK; Chang SY; Chung JM; Oh S; Gwag BJ; Yoo ID
    J Pharmacol Exp Ther; 2001 Oct; 299(1):377-84. PubMed ID: 11561102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-activity relationship of N-(phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists.
    Tamiz AP; Cai SX; Zhou ZL; Yuen PW; Schelkun RM; Whittemore ER; Weber E; Woodward RM; Keana JF
    J Med Chem; 1999 Aug; 42(17):3412-20. PubMed ID: 10464027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Modern aspects of investigation and clinical application of glutamatergic agents].
    Petrov VI; Onishchenko NV
    Eksp Klin Farmakol; 2002; 65(4):66-70. PubMed ID: 12449079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel 3-carboxy- and 3-phosphonopyrazoline amino acids as potent and selective NMDA receptor antagonists: design, synthesis, and pharmacological characterization.
    Conti P; Pinto A; Tamborini L; Madsen U; Nielsen B; Bräuner-Osborne H; Hansen KB; Landucci E; Pellegrini-Giampietro DE; De Sarro G; Donato Di Paola E; De Micheli C
    ChemMedChem; 2010 Sep; 5(9):1465-75. PubMed ID: 20665761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
    Widdowson PS; Gyte AJ; Upton R; Wyatt I
    Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Should N-methyl-D-aspartate or non-N-methyl-D-aspartate glutamate receptor antagonist be used in amyotrophic lateral sclerosis?
    Blin O
    Adv Neurol; 1995; 68():259-61. PubMed ID: 8787238
    [No Abstract]   [Full Text] [Related]  

  • 56. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural basis for understanding structure-activity relationships for the glutamate binding site of the NMDA receptor.
    Tikhonova IG; Baskin II; Palyulin VA; Zefirov NS; Bachurin SO
    J Med Chem; 2002 Aug; 45(18):3836-43. PubMed ID: 12190307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists derived from 3-benzazepines: synthesis and pharmacological evaluation of benzo[7]annulen-7-amines.
    Benner A; Bonifazi A; Shirataki C; Temme L; Schepmann D; Quaglia W; Shoji O; Watanabe Y; Daniliuc C; Wünsch B
    ChemMedChem; 2014 Apr; 9(4):741-51. PubMed ID: 24677663
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond.
    Lipton SA
    Nat Rev Drug Discov; 2006 Feb; 5(2):160-70. PubMed ID: 16424917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. S-methyl-N,N-diethylthiocarbamate sulfoxide elicits neuroprotective effect against N-methyl-D-aspartate receptor-mediated neurotoxicity.
    Ningaraj NS; Chen W; Schloss JV; Faiman MD; Wu JY
    J Biomed Sci; 2001; 8(1):104-13. PubMed ID: 11173983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.